Both peptides show systemic bioactivity but act most strongly at sites of injury or inflammation
The mechanism involves improved fat oxidation rather than appetite suppression
Peptide-based therapies in modern medicine: Opportunities and challenges
The cellular and molecular mechanisms behind this observation involve the up-regulation of caspase 3 and suppression of the proliferation marker ki67 in tumor tissues and cell lines (161)
In a little-publicized 2011 announcement, the FDA acknowledged it was still unable to identify precise toxic thresholds and/or specific populations for whom currently recommended dosages are not safe. A Canadian government study found six people had suffered serious liver damage after taking less than the maximum recommended dose
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected